Skip to main content
Premium Trial:

Request an Annual Quote



In the 09-20-04 issue of BioInform, a quote in the article, “Bayer Spin-off Teams with Physiomics to Develop ‘Virtual Tumor’ for Drug Dosage Testing,” implied that Entelos does not offer a drug delivery model as part of its services. The company said that it has indeed incorporated drug delivery models into its disease models.

In the 09-27-04 issue of BioInform, the Expression Profile Q&A incorrectly listed Frank Brown’s affiliation as Johnson & Johnson’s Pharmaceutical Research Institute instead of Johnson & Johnson Pharmaceutical Research & Development.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.